Live Breaking News & Updates on Philips Healthcare Informatics
Stay updated with breaking news from Philips healthcare informatics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HIMSS22 showed that the industry is back on track, with leading organizations showcasing solutions for staff shortages and related burnout, cybersecurity, digital transformation, image convergence and efficiency ....
HIMSS22 showed that the industry is back on track, with leading organizations showcasing solutions for staff shortages and related burnout, cybersecurity, digital transformation, image convergence and efficiency ....
Integrity Applications, Inc.: Integrity Applications Issues Shareholder Update Letter Dear Fellow Shareholders, 2020 was an important operational year for the Company, even in light of the widespread effects of the COVID-19 pandemic. We hope all of you have stayed healthy and safe during these difficult times. This pandemic has exposed the need for the adoption of innovative digital health technologies for chronic diseases and we believe more than ever that the GlucoTrack platform that we are building will be well suited for addressing the critical market need as it relates to those suffering with diabetes and prediabetes. Talent development, recruiting and organizational health have been a critical focus of the Company over the last 12 months. We are thrilled to have attracted high-quality individuals to the Company, each of whom bring extensive experience in their respective fields. We have bolstered our Senior Management with the recruitment of Erez Ben-Zvi, a highl ....
Integrity Applications Issues Shareholder Update Letter Wilmington, DE and Ashdod, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) Integrity Applications, Inc. (www.integrity-app.com) (IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, issued a letter to its shareholders providing an update on its business. Dear Fellow Shareholders, 2020 was an important operational year for the Company, even in light of the widespread effects of the COVID-19 pandemic. We hope all of you have stayed healthy and safe during these difficult times. This pandemic has exposed the need for the adoption of innovative digital health technologies for chronic diseases and we believe more than ever that the GlucoTrack platform that we are building will be well suited for addressing the critical market need as it relates to those suffering with diabetes and prediabetes. ....